GW&K Investment Management LLC reduced its position in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 7.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 882,796 shares of the medical instruments supplier’s stock after selling 74,645 shares during the quarter. West Pharmaceutical Services accounts for approximately 1.5% of GW&K Investment Management LLC’s investment portfolio, making the stock its 3rd biggest holding. GW&K Investment Management LLC’s holdings in West Pharmaceutical Services were worth $87,105,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. State of Alaska Department of Revenue purchased a new stake in shares of West Pharmaceutical Services during the 4th quarter worth about $532,000. McCollum Christoferson Group LLC purchased a new stake in shares of West Pharmaceutical Services during the 4th quarter worth about $7,650,000. Schwab Charles Investment Management Inc. boosted its stake in shares of West Pharmaceutical Services by 4.3% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 302,973 shares of the medical instruments supplier’s stock worth $29,895,000 after acquiring an additional 12,352 shares in the last quarter. Bank of Montreal Can boosted its stake in shares of West Pharmaceutical Services by 214.3% during the 4th quarter. Bank of Montreal Can now owns 8,788 shares of the medical instruments supplier’s stock worth $867,000 after acquiring an additional 5,992 shares in the last quarter. Finally, National Investment Services Inc. WI purchased a new stake in shares of West Pharmaceutical Services during the 4th quarter worth about $326,000. 93.25% of the stock is currently owned by institutional investors and hedge funds.

Shares of West Pharmaceutical Services Inc. (WST) traded up $2.02 during trading on Friday, reaching $100.61. 351,334 shares of the company were exchanged, compared to its average volume of 336,169. The stock has a market cap of $7,377.77, a price-to-earnings ratio of 40.08, a PEG ratio of 2.04 and a beta of 1.11. West Pharmaceutical Services Inc. has a 1 year low of $77.97 and a 1 year high of $103.36. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.59 and a quick ratio of 1.87.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.14. The firm had revenue of $398.20 million for the quarter, compared to analyst estimates of $386.02 million. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. West Pharmaceutical Services’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company posted $0.53 EPS. equities analysts anticipate that West Pharmaceutical Services Inc. will post 2.76 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, February 1st. Investors of record on Thursday, January 18th will be paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date is Wednesday, January 17th. West Pharmaceutical Services’s dividend payout ratio is presently 22.31%.

In other West Pharmaceutical Services news, CFO William J. Federici sold 21,000 shares of the firm’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $99.01, for a total value of $2,079,210.00. Following the transaction, the chief financial officer now directly owns 190,493 shares of the company’s stock, valued at approximately $18,860,711.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.90% of the company’s stock.

A number of research analysts recently weighed in on WST shares. Bank of America lowered shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price target on the stock. in a research note on Tuesday, October 17th. Wells Fargo & Co raised their price target on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the company an “outperform” rating in a research note on Friday, October 27th. Zacks Investment Research raised shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Wednesday, September 27th. Finally, Stephens started coverage on shares of West Pharmaceutical Services in a research note on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $106.00.

COPYRIGHT VIOLATION NOTICE: “GW&K Investment Management LLC Sells 74,645 Shares of West Pharmaceutical Services Inc. (WST)” was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dailypolitical.com/2018/01/19/gwk-investment-management-llc-sells-74645-shares-of-west-pharmaceutical-services-inc-wst.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.